In our short history, III has made a number of achievements in the fields of infection and immunity. Some of these success stories are featured here. Also included here are commentary and background on current events, facts and figures, and a look at some of the behind-the-scenes activities III is involved in to develop partnerships and research responses to issues in infection and immunity.

For an overview of how we are achieving our objectives, read our Overview of Achievements 2000-2005.
[ HTML | PDF (379 KB) | Help ]

Evaluation of Institute Initiatives

• Evaluation of the Pilot Project Grants for New Investigators Program 2003

Infectious Diseases

• Emerging Infectious Disease
  • A Summary of the Canadian SARS Research Consortium (CSRC)
    [ HTML | PDF (117 KB) | Help ]
    
    
• Microbiologically Safe Food and Water
  
  • A Partnership for Safe Food and Water
  • Canadian Research Coalition for Safe Food and Water
    
    • Summary [ HTML | PDF (136 KB) | Help ]
    • Article
      
      
• Hepatitis C

• HIV/AIDS
  
  
• Unique Challenges
  
  • Transplantation and Regenerative Medicine
    Transnet: Illuminating the immune response to transplantation
    
    
• Novel Vaccine Development
  
  • Canadian International Immunization Initiative, Phase 2 
  • A 21st Century Approach to Vaccine Development
  • Toward a National Immunization Strategy for Canada

Host Response

• Autoimmune Diseases
  
  • Working to improve quality of life for those living with diabetes: An interview with Dr. George Fantus
  • III & JDRF Search for a Cure for Type 1 Diabetes

• Asthma and Allergy
  
  • III New Emerging Team Tackles Asthma
  • Allergy and asthma: From molecular regulation to population health

Miscellaneous

• The "Triple - I" Impact Factor
  [ HTML | PDF (136 KB) | Help ]

• Calling a New Generation of Oral Health Researchers

• Graduate Training Program in Public Health and the Agricultural Rural Ecosystem (PHARE)
  
• New Collaboration Supports Research in Complementary and Alternative Medicine [ HTML | PDF (100 KB) | Help ]